Should I buy or sell Curaleaf stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last twelve months. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CURLF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CURLF, but not buy additional shares or sell existing shares. View CURLF analyst ratings or view top-rated stocks .

What is Curaleaf's stock price target for 2024?

5 analysts have issued twelve-month price targets for Curaleaf's stock. Their CURLF share price targets range from $5.25 to $32.25. On average, they expect the company's share price to reach $18.75 in the next twelve months. This suggests a possible upside of 279.6% from the stock's current price. View analysts price targets for CURLF or view top-rated stocks among Wall Street analysts .

How have CURLF shares performed in 2024?

Curaleaf's stock was trading at $4.06 at the start of the year. Since then, CURLF shares have increased by 21.7% and is now trading at $4.94. View the best growth stocks for 2024 here .

When is Curaleaf's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 29th 2024. View our CURLF earnings forecast .

How were Curaleaf's earnings last quarter?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) released its quarterly earnings data on Wednesday, March, 6th. The company reported ($0.01) earnings per share for the quarter, beating analysts' consensus estimates of ($0.05) by $0.04. The business had revenue of $345.27 million for the quarter, compared to analyst estimates of $336.64 million. Curaleaf had a negative net margin of 20.77% and a negative trailing twelve-month return on equity of 12.93%.

How do I buy shares of Curaleaf?

Shares of CURLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:CURLF

Curaleaf (CURLF) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free CURLF Stock Alerts

$4.94

-0.13 (-2.56%)

(As of 04/19/2024 ET)

Compare

Today's Range: $4.93
▼
$5.13
50-Day Range: $3.85
▼
$5.65
52-Week Range: $2.19
▼
$5.91

Volume: 326,848 shs
Average Volume: 659,640 shs
Market Capitalization: $3.18 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $18.75

Stock Analysis Analyst Forecasts Chart Earnings Financials Headlines SEC Filings Short Interest

Get Curaleaf alerts:

Curaleaf MarketRank™ Stock Analysis

Analyst Rating: Hold
2.40 Rating Score
Upside/Downside: 279.6% Upside
$18.75 Price Target
Short Interest: Healthy
0.73% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.25
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.18) to ($0.07) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.20 out of 5 stars

3.2

Analyst's Opinion

Consensus Rating
Curaleaf has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 3 buy ratings, 1 hold rating, and 1 sell rating.
Amount of Analyst Coverage
Curaleaf has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.73% of the outstanding shares of Curaleaf have been sold short.
Short Interest Ratio / Days to Cover
Curaleaf has a short interest ratio ("days to cover") of 4.
Change versus previous month
Short interest in Curaleaf has recently decreased by 4.12%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Curaleaf does not currently pay a dividend.
Dividend Growth
Curaleaf does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CURLF.

1.8

News and Social Media Coverage

News Sentiment
Curaleaf has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Consumer Discretionary companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Curaleaf this week, compared to 3 articles on an average week.
Search Interest
Only 12 people have searched for CURLF on MarketBeat in the last 30 days. This is a decrease of -8% compared to the previous 30 days.
MarketBeat Follows
Only 12 people have added Curaleaf to their MarketBeat watchlist in the last 30 days. This is a decrease of -14% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Curaleaf insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.03% of the stock of Curaleaf is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Curaleaf are expected to grow in the coming year, from ($0.18) to ($0.07) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Curaleaf is -12.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Curaleaf is -12.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Curaleaf has a P/B Ratio of 3.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Curaleaf Stock (OTCMKTS:CURLF)

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

CURLF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CURLF Stock News Headlines

April 20, 2024 | proactiveinvestors.com

4/20 2024: Cannabis investors have much to celebrate this year

April 17, 2024 | finance.yahoo.com

Curaleaf Holdings, Inc. (CURLF)

April 20, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

April 17, 2024 | fool.com

The Best Cannabis Stock to Invest $1,000 in Right Now

April 16, 2024 | msn.com

Global Cannabis Strategies Post-German Legalization: Exclusive Insights From Curaleaf, Gold Flora, Verano

April 16, 2024 | investorplace.com

3 Cannabis Penny Stocks to Buy for 3-Bagger Returns

April 12, 2024 | investorplace.com

3 High-Potential Penny Stocks to Turn $100,000 Into $1 Million: April 2024

April 11, 2024 | finance.yahoo.com

Curaleaf Holdings, Inc.: Curaleaf's Medium-Term Growth Should Benefit From Its European Investments and US Market Expansions

April 20, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

April 11, 2024 | markets.businessinsider.com

This Dividend-Paying Cannabis Stock Had Higher 1-Year Return Than Tesla, Citigroup, Apple And Zillow

April 10, 2024 | msn.com

Weeding Out Misinformation: Curaleaf And Acannability's Educational Collab For Cannabis Consumer Awareness

April 9, 2024 | msn.com

Cannabis Grower Curaleaf Ponders Secondary Europe Listing

April 8, 2024 | msn.com

154 Pounds Of Weed Found In French Mayor's Home, Denmark Closes Pot Street In Christiania After Multiple Shootings & More Cannabis Euro News

April 8, 2024 | investorplace.com

Wall Street Favorites: 3 Cannabis Stocks with Strong Buy Ratings for April 2024

April 6, 2024 | msn.com

Cannabis rally sparks concerns amid moves to mainstream

April 5, 2024 | msn.com

New York judge strikes down state’s marijuana marketing laws

April 5, 2024 | msn.com

Curaleaf reportedly eyeing stock listing in Europe

April 4, 2024 | msn.com

Trulieve-led Florida adult-use cannabis campaign gathers steam

April 4, 2024 | prnewswire.com

Curaleaf to Report First Quarter 2024 Financial and Operational Results

April 2, 2024 | msn.com

The 3 Most Undervalued Cannabis Stocks to Buy in April 2024

March 30, 2024 | msn.com

Cannabis Company AYR Wellness Launches Gluten-Free Vegan Edibles, Targets $2B Market

March 27, 2024 | investorplace.com

Wake Up to Wealth: 7 Sleeper Stocks Ready to Roar

March 26, 2024 | investorplace.com

3 Cannabis Stocks That Could Be Multibaggers in the Making: March Edition

March 25, 2024 | finance.yahoo.com

Navigating Regulatory Changes: 10 Cannabis ETFs To Explore

March 22, 2024 | businesswire.com

Curaleaf International Comments As German Federal Cannabis Law Passes Without Delay

March 21, 2024 | investorplace.com

7 Growth Stocks That Could Turn $10,000 into $70,000 by 2028

March 20, 2024 | investorplace.com

Wall Street's Favorite Cannabis Stocks? 3 Names That Could Make You Filthy Rich

See More Headlines

Receive CURLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curaleaf and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/06/2024
Today: 4/20/2024
Next Earnings (Estimated): 4/29/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Consumer Discretionary
Industry: Medicinals & botanicals
Sub-Industry: N/A
Current Symbol: OTCMKTS:CURLF
CUSIP: N/A
CIK: 1756770
Web: www.curaleaf.com
Phone: 781-451-0351
Fax: N/A
Employees: 5,650
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $18.75
High Stock Price Target: $32.25
Low Stock Price Target: $5.25
Potential Upside/Downside: +279.6%
Consensus Rating: Hold
Rating Score (0-4): 2.40
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.39)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-281,200,000.00
Net Margins: -20.77%
Pretax Margin: -9.24%
Return on Equity: -12.93%
Return on Assets: -4.65%

Debt

Debt-to-Equity Ratio: 0.87
Current Ratio: 0.85
Quick Ratio: 0.41

Sales & Book Value

Annual Sales: $1.35 billion
Price / Sales: 2.36
Cash Flow: $0.14 per share
Price / Cash Flow: 35.12
Book Value: $1.64 per share
Price / Book: 3.01

Miscellaneous

Outstanding Shares: 642,740,000
Free Float: N/A
Market Cap: $3.18 billion
Optionable: Not Optionable
Beta: 1.77

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Mr. Boris Alexis Jordan (Age 58)
Executive Chairman
Comp: $1.75M
Mr. Matthew S. Darin
Chief Executive Officer
Mr. Joseph F. Lusardi (Age 50)
Executive Vice-Chairman
Comp: $657.7k
Mr. Edward Kremer (Age 52)
Chief Financial Officer
Comp: $461.74k
Mr. Camilo Russi Lyon
Chief Investment Officer
Mr. Jakob Feinstein
Manager of Investor Relations
Mr. Peter Laurence Clateman J.D. (Age 56)
Chief Legal Officer
Mr. James S. Shorris (Age 63)
Chief Compliance Officer
Ms. Tracy Brady
Senior Vice President of Corporate Communications
Ms. Kate Lynch
Executive Vice President of Marketing

Key Competitors

View All Competitors

CURLF Stock Analysis - Frequently Asked Questions

Should I buy or sell Curaleaf stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last twelve months. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CURLF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CURLF, but not buy additional shares or sell existing shares.
View CURLF analyst ratings or view top-rated stocks.
What is Curaleaf's stock price target for 2024?: 5 analysts have issued twelve-month price targets for Curaleaf's stock. Their CURLF share price targets range from $5.25 to $32.25. On average, they expect the company's share price to reach $18.75 in the next twelve months. This suggests a possible upside of 279.6% from the stock's current price.
View analysts price targets for CURLF or view top-rated stocks among Wall Street analysts.
How have CURLF shares performed in 2024?: Curaleaf's stock was trading at $4.06 at the start of the year. Since then, CURLF shares have increased by 21.7% and is now trading at $4.94.
View the best growth stocks for 2024 here.
When is Curaleaf's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, April 29th 2024.
View our CURLF earnings forecast.

How were Curaleaf's earnings last quarter?: Curaleaf Holdings, Inc. (OTCMKTS:CURLF) released its quarterly earnings data on Wednesday, March, 6th. The company reported ($0.01) earnings per share for the quarter, beating analysts' consensus estimates of ($0.05) by $0.04. The business had revenue of $345.27 million for the quarter, compared to analyst estimates of $336.64 million. Curaleaf had a negative net margin of 20.77% and a negative trailing twelve-month return on equity of 12.93%.
How do I buy shares of Curaleaf?: Shares of CURLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CURLF) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial